🚀
Enjoy a 7-Day Free Trial Thru Nov 13, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Strategies Created by Users
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Canadian Insider
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
Instant Alerts
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruAI
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
All Topics
General Discussions
Investment Ideas
Strategies
Article Comments
Books
Feedback
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Incyte Corp (NAS:INCY)
Transcripts
Incyte Corp (NAS:INCY)
$ 77.28
1.53 (2.02%)
Market Cap: 14.89 Bil
Enterprise Value: 12.86 Bil
PE Ratio: 552.00
PB Ratio: 4.70
GF Score: 92/100
0
Summary
30-Y Financials
Forecast
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Incyte Corp (INCY) Transcripts
Q3 2024 Incyte Corp Earnings Call Transcript
Oct 29, 2024
$73.6
(+12.04%)
Earnings
Show Key Points
Q2 2024 Incyte Corp Earnings Call Transcript
Jul 30, 2024
$67.79
(-1.17%)
Earnings
Show Key Points
Q1 2024 Incyte Corp Earnings Call Transcript
Apr 30, 2024
$52.05
(-0.97%)
Earnings
Q4 2023 Incyte Corp Earnings Call Transcript
Feb 13, 2024
$59.34
(+2.59%)
Earnings
Incyte Corp at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Incyte Corp at Goldman Sachs Healthcare C-Suite Unscripted Conference Transcript
Jan 04, 2024
Incyte Corp to Discuss the Key Data Presentations at ASH Transcript
Dec 11, 2023
Incyte Corp at Evercore ISI HealthCONx Conference Transcript
Nov 30, 2023
Incyte Corp at Guggenheim Securities Inflammation & Immunology Conference Transcript
Nov 07, 2023
Q3 2023 Incyte Corp Earnings Call Transcript
Oct 31, 2023
$53.93
(+3.39%)
Earnings
Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 14, 2023
Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Incyte Corp at Wells Fargo Healthcare Conference Transcript
Sep 07, 2023
Q2 2023 Incyte Corp Earnings Call Transcript
Aug 01, 2023
$63.69
(-0.05%)
Earnings
Incyte Corp at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023
Incyte Corp at William Blair Growth Stock Conference Transcript
Jun 06, 2023
Incyte Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 16, 2023
Incyte Corp at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Incyte Corp Earnings Call Transcript
May 02, 2023
$69.96
(-7.14%)
Earnings
Incyte Corp at Cowen Health Care Conference Transcript
Mar 06, 2023
Incyte Corp at Guggenheim Healthcare Talks Oncology Day Transcript
Feb 08, 2023
Q4 2022 Incyte Corp Earnings Call Transcript
Feb 07, 2023
$80.96
(-4.03%)
Earnings
Incyte Corp at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Incyte Corp at Goldman Sachs CEOs Unscripted Conference Transcript
Jan 05, 2023
Incyte Corp Analyst and Investor Event Transcript
Dec 12, 2022
Incyte Corp at Bank of America Biotech SMID Cap Conference Transcript
Dec 07, 2022
Incyte Corp at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 29, 2022
Q3 2022 Incyte Corp Earnings Call Transcript
Nov 01, 2022
$76.95
(+3.51%)
Earnings
Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022
Q2 2022 Incyte Corp Earnings Call Transcript
Aug 02, 2022
$72.58
(-6.23%)
Earnings
Incyte Corp to Discuss Opzelura In Vitiligo FDA Approval Call Transcript
Jul 19, 2022
Incyte Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022
Incyte Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2022
Q1 2022 Incyte Corp Earnings Call Transcript
May 03, 2022
$77.18
(+1.49%)
Earnings
Incyte Corp at Cowen Health Care Conference (Virtual) Transcript
Mar 07, 2022
Incyte Corp at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022
Q4 2021 Incyte Corp Earnings Call Transcript
Feb 08, 2022
$70.07
(-4.47%)
Earnings
Incyte Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Incyte Corp at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript
Jan 06, 2022
Incyte Corp at Evercore ISI HealthCONx Virtual Conference Transcript
Nov 30, 2021
Incyte Corp to Discuss Highlights from Oral PD-L1 Program from SITC Transcript
Nov 13, 2021
Incyte Corp at BMO Capital Markets Biopharma Spotlight Series: Oncology (Virtual) Transcript
Nov 08, 2021
Q3 2021 Incyte Corp Earnings Call Transcript
Nov 02, 2021
$63.48
(-8.46%)
Earnings
Incyte Corp GVHD Update Call: Approval in cGVHD and Syndax Collaboration Transcript
Sep 27, 2021
Syndax Pharmaceuticals Inc and Incyte Corp Axatilimab Collaboration Call Transcript
Sep 27, 2021
Incyte Corp to Discuss Opzelura (ruxolitinib) Cream FDA Approval Call Transcript
Sep 22, 2021
Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021
Q2 2021 Incyte Corp Earnings Call Transcript
Aug 03, 2021
$77.95
(-0.66%)
Earnings
Incyte Corp at Guggenheim Biopharma's Next Decade Virtual Conference Transcript
Jun 28, 2021
Incyte Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
Incyte Corp Sustainability Roundtable's CEO Investor Forum Transcript
Jun 07, 2021
Incyte Corp at William Blair Growth Stock Conference (Virtual) Transcript
Jun 03, 2021
Incyte Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021
Q1 2021 Incyte Corp Earnings Call Transcript
May 04, 2021
$81.03
(-5.25%)
Earnings
Incyte Corp Data Highlights on Adenosine Program from AACR 2021 Transcript
Apr 12, 2021
Incyte Corp at Cowen Healthcare Conference (Virtual) Transcript
Mar 03, 2021
Q4 2020 Incyte Corp Earnings Call Transcript
Feb 09, 2021
$89.46
(-4.44%)
Earnings
Incyte Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Incyte Corp Data Highlights from ASH 2020 Transcript
Dec 07, 2020
Incyte Corp at Evercore ISI HealthCONx Conference Transcript
Dec 01, 2020
Q3 2020 Incyte Corp Earnings Call Transcript
Nov 05, 2020
$84.65
(-7.19%)
Earnings
MorphoSys AG and Incyte Corp to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas Investor Call Transcript
Sep 29, 2020
Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Q2 2020 Incyte Corp Earnings Call Transcript
Aug 04, 2020
$99.95
(-1.81%)
Earnings
Incyte Corp at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript
Jun 23, 2020
Incyte Corp at JMP Securities Life Sciences Conference Transcript
Jun 18, 2020
Incyte Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2020
Incyte Corp at RBC Global Healthcare Conference Transcript
May 19, 2020
Q1 2020 Incyte Corp Earnings Call Transcript
May 05, 2020
$98.82
(-2.15%)
Earnings
Incyte Corporation - Pemazyre FDA Approval Transcript
Apr 20, 2020
Incyte Corp Corporate Call - Data from Phase 3 TRuE-AD Trials of Ruxolitinib Cream in Atopic Dermatitis Transcript
Apr 06, 2020
Incyte Corp at Cowen HealthCare Conference Transcript
Mar 02, 2020
Q4 2019 Incyte Corp Earnings Call Transcript
Feb 13, 2020
$78.05
(+2.93%)
Earnings
Incyte Corp at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
MorphoSys AG and Incyte Sign Global Collaboration and License Agreement for Tafasitamab Conference Call Transcript
Jan 13, 2020
Incyte Corp GRAVITAS-301 Call Transcript
Jan 02, 2020
Incyte Corp at Piper Jaffray Healthcare Conference Transcript
Dec 04, 2019
Incyte Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019
Q3 2019 Incyte Corp Earnings Call Transcript
Oct 29, 2019
$83.35
(+4.37%)
Earnings
Incyte Corp Call to Discuss Pemigatinib Development Update from European Society for Medical Oncology Transcript
Sep 27, 2019
Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 18, 2019
Incyte Corp at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
Q2 2019 Incyte Corp Earnings Call Transcript
Jul 30, 2019
$85.43
(+6.44%)
Earnings
Zai Lab Ltd and Incyte Corp to Discuss the Collaboration and License Agreement for INCMGA0012 in Greater China Call Transcript
Jul 02, 2019
Incyte Corp Key Studies Within Its Inflammation And Autoimmunity portfolio Corporate Call Transcript
Jun 17, 2019
Incyte Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019
Incyte Corp at RBC Capital Markets Healthcare Conference Transcript
May 21, 2019
Incyte Corp at UBS Global Healthcare Conference Transcript
May 20, 2019
Incyte Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
Q1 2019 Incyte Corp Earnings Call Transcript
Apr 30, 2019
$76.8
(+3.25%)
Earnings
Incyte Corp at Barclays Global Healthcare Conference Transcript
Mar 13, 2019
Incyte Corp at Cowen and Company Health Care Conference Transcript
Mar 11, 2019
Q4 2018 Incyte Corp Earnings Call Transcript
Feb 14, 2019
$83.42
(+2.91%)
Earnings
1